Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at
opm.gov.
Development of Nanomedicines for Tuberculosis Treatment
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Development of Nanomedicines for Tuberculosis Treatment
Principal Institution
University of the Western Cape
Principal Investigator(s) (PI)
Dube, Admire
Project Contact Information
Email: adube@uwc.ac.za
Year(s) Awarded
2017-2023
Country
South Africa
Collaborators
University at Buffalo
Project Description
The overall goal of this project is to provide advanced training to equip Dr. Admire Dube (a scientist in nanotechnology) with skills and competencies in the biology and immunology of infectious diseases. These skills will equip Dr. Dube to establish a research career in the development of nanomedicines for the treatment of infectious diseases. The burden of infectious diseases is a global concern, particularly in Africa where Dr. Dube is resident.
Related World Regions / Countries
Related Global Health Research Topics